Get started
Author

Yoshitaka Fujiki

Observed names: Fujiki Yoshitaka, Fujiki, Yoshitaka, Y Fujiki, Y. Fujiki, Yoshitaka FUJIKI
Institution: Sagara Hospital
ORCID: 0000-0001-8557-0683
Observed ORCID: 0000-0001-8557-0683
OpenAlex ID: A5044478653
Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
2016 · Mai Tomiguchi, Yutaka Yamamoto, et al. · Cancer Science · 55
PDF
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
2012 · Chunsen Xu, Mutsuko Yamamoto-Ibusuki, et al. · Breast Cancer · 47
Exosomal miRNA profiles of triple‑negative breast cancer in neoadjuvant treatment
2021 · Aiko Sueta, Yoshitaka Fujiki, et al. · Oncology Letters · 46
PDF
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling
2018 · Lisa Goto-Yamaguchi, Mutsuko Yamamoto-Ibusuki, et al. · Breast Cancer Research and Treatment · 23
APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
2018 · Yoshitaka Fujiki, Yutaka Yamamoto, et al. · Oncotarget · 10
Predictive and prognostic significance of BRCAness in HER2-negative breast cancer
2022 · Aiko Sueta, Mutsuko Yamamoto-Ibusuki, et al. · Breast Cancer · 7
Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective study
2025 · Y. Ozaki, E. Tokuda, et al. · ESMO Open · 2
PDF
Association of response to neoadjuvant chemotherapy (NAC) in premenopausal patients with hormone receptor-positive early breast cancer with chemotherapy-induced ovarian function suppression by NAC.
2012 · Yutaka Yamamoto, Risa Yamaguchi, et al. · Journal of Clinical Oncology · 2
Abstract P4-07-21: Prognostic analysis of operable HR-positive HER2-negative loco-regional recurrent breast cancer; A multi-institutional Retrospective Cohort Study
2025 · Emi Tokuda, Yukinori Ozaki, et al. · Clinical Cancer Research · 1
Incidence and clinical relevance of ESR1 mutations in estrogen receptor positive breast cancer patients
2017 · Takashi Takeshita, Mai Tomiguchi, et al. · Annals of Oncology · 1
PDF
Postoperative course and safety profile of the suture scaffold technique in breast-conserving surgery: a single-institution observational study
2025 · Reiko Mitsueda, Yasuyo Ohi, et al. · Breast Cancer
Benefit of perioperative chemotherapy in the patients with loco-regional recurrence of HR-positive HER2-negative breast cancer: A multi-institutional retrospective cohort study.
2024 · Yukinori Ozaki, Emi Tokuda, et al. · Journal of Clinical Oncology
Abstract P3-18-13: A cross-sectional study to investigate association between oncoplastic techniques and patient satisfaction who received breast-conserving surgery
2022 · Reiko Mitsueda, Anri Gen, et al. · Cancer Research
Abstract P5-11-12: Clinical value of ESR1 mutations from cell free DNA in ethynil estradiol treatment for metastatic breast cancer
2020 · Hirotaka Iwase, Takashi Takeshita, et al. · Cancer Research
Marine-Lenhart Syndrome Diagnosed during Follow-up of a Thyroid Nodule—A Case Report—
2020 · Yoshitaka FUJIKI, Syuichi KANEMITSU, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
PDF
Apobec3b遺伝子発現は原発性乳癌における術前化学療法に対する病理学的完全奏効の新規予測因子である
2018 · Fujiki, Yoshitaka · Institutional Repositories DataBase (IRDB)
“BRCAness”; a potential predictor needing the additional therapeutics
2017 · M. Yamamoto-Ibusuki, Y. Yamamoto, et al. · The Breast
Abstract P6-09-48: Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
2017 · Y Fujiki, Y Yamamoto, et al. · Cancer Research
A case of premenopausal breast cancer with symptomatic cerebellar metastasis successfully treated by systemic endocrine therapy alone: relationship to biological features
2016 · Yoshitaka Fujiki, Yutaka Yamamoto, et al. · International Cancer Conference Journal
PDF
乳癌患者の原発,再発転移巣,血液検体におけるesr1リガンド結合ドメインの遺伝子変異解析
2016 · Takeshita Takashi, Tomiguchi Mai, et al. · 日本癌学会学術総会抄録集(Web)
線維芽細胞増殖因子受容体‐1蛋白質発現はエストロゲン受容体‐陽性/ヒト上皮細胞増殖因子受容体‐2‐陰性原発性乳癌における予後と関連する
2016 · Tomiguchi Mai, Yamamoto Yutaka, et al. · Cancer Science
Works count: 21
Citation count: 194
H-index: 6
I10-index: 5
Year
Topic
Type